Variceal bleeding - Causes, Treatment & When to See a Doctor

```html

What is Variceal Bleeding?

Variceal bleeding is a potentially life‑threatening loss of blood that occurs when dilated veins (varices) rupture. The most common site for varices is the esophagus, but they can also develop in the stomach, rectum, or around the umbilicus. These veins become enlarged because of abnormally high pressure in the portal venous system—a condition known as portal hypertension—most often caused by liver disease. When a varix ruptures, blood can pour into the gastrointestinal tract, leading to vomiting of blood (hematemesis), black tarry stools (melena), or bright red rectal bleeding.

Because the bleeding can be rapid and massive, prompt recognition and treatment are essential. The condition is a medical emergency that requires evaluation by a gastroenterologist, hepatologist, or an emergency‑medicine physician.<sup>1</sup>

Common Causes

The underlying factor for variceal formation is portal hypertension, but several diseases and conditions can lead to that high pressure:

• Cirrhosis of the liver – most common cause (alcoholic, viral hepatitis, non‑alcoholic steatohepatitis, etc.).
• Schistosomiasis – parasitic infection that damages liver vasculature.
• Portal vein thrombosis – clot blocking portal blood flow.
• Budd‑Chiari syndrome – obstruction of hepatic veins.
• Congenital hepatic fibrosis – a rare developmental disorder.
• Autoimmune hepatitis – chronic inflammation leading to scarring.
• Primary sclerosing cholangitis (PSC) – inflammation of bile ducts causing fibrosis.
• Hemochromatosis – iron overload that eventually leads to cirrhosis.
• Wilson disease – copper accumulation with secondary liver damage.
• Severe hepatic congestion from heart failure – especially right‑sided heart failure.

Associated Symptoms

Variceal bleeding rarely occurs in isolation. The following clinical features often accompany or precede the bleed:

• History of chronic liver disease (jaundice, ascites, spider angiomas).
• Upper‑abdominal discomfort or fullness.
• Vomiting of fresh blood (hematemesis) or coffee‑ground‑like material.
• Black, tarry stools (melena) indicating digested blood.
• Bright red blood per rectum if bleeding is distal (rectal varices).
• Signs of anemia – fatigue, dizziness, pallor, shortness of breath.
• Confusion or encephalopathy due to liver dysfunction.
• Abdominal distension from ascites.

When to See a Doctor

Because variceal bleeding can progress from minor to catastrophic within minutes, seek medical attention immediately if you notice any of the following:

• Vomiting blood or material that looks like coffee grounds.
• Black, tarry stools or bright red blood from the rectum.
• Sudden weakness, fainting, or rapid heartbeat.
• Severe abdominal pain combined with any of the above.
• New onset of confusion, especially in someone with known liver disease.

Even if bleeding seems minor, patients with cirrhosis should call their hepatology team right away, as early endoscopic evaluation often prevents a catastrophic bleed.

Diagnosis

Evaluation of suspected variceal bleeding proceeds rapidly to confirm the source and assess severity.

Initial Assessment

• Vital signs – blood pressure, heart rate, oxygen saturation, temperature.
• Physical exam – look for stigmata of chronic liver disease, abdominal distension, and signs of shock.
• Laboratory tests – CBC (hemoglobin/hematocrit), coagulation panel (INR, PT), liver function tests, renal panel, and blood type & cross‑match.

Imaging & Endoscopy

• Upper endoscopy (esophagogastroduodenoscopy, EGD) – gold standard for locating esophageal or gastric varices and for immediate therapeutic interventions (band ligation, sclerotherapy).
• Trans‑jugular intrahepatic portosystemic shunt (TIPS) planning – often guided by Doppler ultrasound or CT to assess portal vein anatomy.
• Contrast‑enhanced CT or MRI – helpful when bleeding source is unclear or when abdominal complications (splenomegaly, ascites) need evaluation.

Scoring Severity

Clinicians may use the Child‑Pugh or MELD scores to gauge liver disease severity, which influences treatment choices and prognosis.<sup>2</sup>

Treatment Options

Treatment aims to stop the bleed, prevent re‑bleeding, and manage the underlying portal hypertension.

Acute Management (Emergency)

• Resuscitation – rapid IV crystalloid infusion, transfusion of packed red blood cells (target hemoglobin 7–9 g/dL). Restrictive transfusion strategies improve outcomes in cirrhotic patients.<sup>3</sup>
• Pharmacologic therapy
  • Octreotide (somatostatin analogue) 50 µg IV bolus followed by 50 µg/h infusion reduces portal pressure.
  • Vasopressin* (or terlipressin) – used where octreotide unavailable; requires careful monitoring for ischemic side effects.
  • Proton‑pump inhibitors – given to cover possible co‑existent peptic ulcer bleeding.
• Endoscopic therapy – performed within 12 hours of presentation if the patient is stable.
  • Endoscopic band ligation (EBL) – first‑line for esophageal varices.
  • Sclerotherapy – alternative when banding not feasible.
  • Cauterization / Hemostatic clips – for gastric varices (often combined with tissue‑gluing agents).

Rescue & Definitive Therapy

• Trans‑jugular intrahepatic portosystemic shunt (TIPS) – creates a low‑resistance channel between portal and hepatic veins, lowering portal pressure. Indicated when endoscopic control fails or re‑bleeding occurs.<sup>4</sup>
• Balloon‑tamponade (Sengstaken-Blakemore tube) – temporary mechanical compression of esophageal varices for patients in uncontrolled hemorrhagic shock; used only as a bridge to definitive therapy.
• Liver transplantation – the only curative option for end‑stage cirrhosis with recurrent variceal bleeding.

Long‑Term Management & Home Care

• Non‑selective beta‑blockers (NSBBs) – propranolol or nadolol to lower portal pressure; target heart rate 55–60 bpm.
• Repeat surveillance endoscopy – every 1–2 years in patients with cirrhosis without prior bleed, and every 6‑12 months after a bleed.
• Alcohol abstinence – critical for patients with alcoholic liver disease.
• Nutritional support – high‑protein diet (unless hepatic encephalopathy mandates restriction), adequate calories, and vitamin supplementation.
• Vaccinations – hepatitis A/B, pneumococcal, and annual influenza to reduce infection risk.

Prevention Tips

While you cannot eliminate portal hypertension completely, several steps can dramatically lower the risk of a first bleed or re‑bleeding:

• Control underlying liver disease – treat viral hepatitis, manage metabolic syndrome, and avoid hepatotoxic substances.
• Take prescribed beta‑blockers consistently – do not stop without discussing with your doctor.
• Schedule regular endoscopic screenings – early detection of small varices allows prophylactic band ligation.
• Maintain a healthy weight – obesity worsens insulin resistance and fatty liver disease.
• Limit NSAID use – NSAIDs increase gastrointestinal bleeding risk and may worsen portal pressure.
• Vaccinate and practice good hygiene – prevents infections that can precipitate decompensation.
• Adhere to fluid and sodium restrictions if you have ascites, to avoid worsening portal hypertension.
• Avoid smoking – smoking accelerates liver fibrosis.

Emergency Warning Signs

If any of the following occur, call 911 or go to the nearest emergency department immediately:

• Vomiting large amounts of bright red blood or coffee‑ground material.
• Passing large volumes of black, tarry stools (melena) or bright red blood per rectum.
• Sudden drop in blood pressure (systolic < 90 mm Hg) or rapid heart rate (> 120 bpm).
• Severe dizziness, fainting, or confusion.
• Chest or abdominal pain that is worsening rapidly.
• Signs of shock: cold, clammy skin; rapid shallow breathing; reduced urine output.

References

1. Mayo Clinic. “Esophageal varices.” Updated 2023. https://www.mayoclinic.org
2. American Association for the Study of Liver Diseases (AASLD). “Guidelines for the management of portal hypertension.” 2022.
3. Villanueva C, et al. “Restrictive transfusion strategy for acute upper gastrointestinal bleeding in cirrhosis.” *New England Journal of Medicine*, 2020; 382: 1219‑1230.
4. Garcia‑Perez RO, et al. “Transjugular intrahepatic portosystemic shunt for refractory variceal bleeding.” *Hepatology*, 2021; 73(5): 1668‑1680.
5. Centers for Disease Control and Prevention (CDC). “Vaccination recommendations for people with liver disease.” 2023.

```